Genetically Proxied SGLT2 Inhibition and Risk of Epilepsy: A Mediation Mendelian Randomization Study of Circulating Metabolites.

Research paper from Europe PMC. Evidence status: source reported.

Published

2026-10-21

Source reference

MED:42940212

DOI

10.3390/biomedicines14102406

Jurisdiction

Not assessed

Licence

Bibliographic metadata only; article rights retained

Chang M, Li J, Gu F, Wu X, Song B, Chen Z, Wang Z. · Biomedicines · research-article; journal article · Found via: UK Biobank

Source: https://europepmc.org/article/MED/42940212. Captured 2026-10-31.

Limitations: Discovered through a Europe PMC keyword search for UK Biobank. A mention is not a verified link to an access authorisation, project, dataset or clinical outcome. Preprints may not be peer reviewed.